Phase 1 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 2 diabetes mellitus (T2DM)
- People whose Body Mass Index (BMI) falls between 18 and 40 kg/m², inclusive (BMI is a measure based on height and weight)
Who may not be able to join:
- People who have Type 1 diabetes or other forms of diabetes that are caused by another medical condition
- People who have a history of severe heart failure (classified as NYHA Class 3 or 4, meaning significant limitations on physical activity)
- People who have a history of heart attack, uncontrolled irregular heartbeats, heart bypass or similar heart procedures, chest pain from heart disease, unstable circulation problems in the limbs, or stroke
- People who have a history of cancer
- People whose blood tests show current or past infection with hepatitis B, hepatitis C, or HIV
- People who have a history of stomach or digestive conditions that could affect how food or medication is absorbed, or who have had gastric bypass or similar weight-loss surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Merck Sharp & Dohme LLC
Phone: 1-888-577-8839
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants who experience one or more adverse events (AE); Number of participants who discontinue study intervention due to adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.